Bone health may come up when you discuss low testosterone, especially if a scan has shown low density or you have already broken a bone. It is reasonable to ask how hormone treatment fits, but the answer should distinguish a scan result from the risk of an actual fracture.
A plan for osteoporosis or falls may involve decisions beyond testosterone. This guide helps you ask which problem each treatment is intended to address and what evidence supports the recommendation.
- Bone density is a different outcome from fracture prevention.
- TRAVERSE did not show fewer fractures with testosterone gel.
- Discuss osteoporosis and fall risk as their own clinical concerns.
Clarify what the scan is telling you
Bone mineral density testing contributes to evaluating osteoporosis and fracture risk. NIAMS explains that measures such as T-scores help clinicians interpret the scan within the appropriate setting. The result should be considered with other information, including previous fractures and relevant medical history.
Ask what the result means for your own care and whether it changes the recommended evaluation. A testosterone blood test answers a different question. Neither should be used as a shortcut around understanding the other.
Ask whether the study measured fractures
The TRAVERSE fracture subtrial studied 5,204 men aged 45–80 with hypogonadism and cardiovascular disease or elevated cardiovascular risk. Daily testosterone gel did not lower clinical-fracture incidence compared with placebo. Over a median 3.19 years, fractures were reported in 3.50% and 2.46% of the groups, respectively.
Those findings apply to the studied population and approach; they do not compare every formulation. They also show why a change in bone density cannot be treated as proof that a treatment prevents broken bones.
Bring the wider risk history
Tell the clinician about previous fractures, falls, balance problems, relevant medicines, and any existing osteoporosis treatment. Ask whether further testing or another specialist’s advice is appropriate. These questions remain important even when testosterone deficiency is also present.
Do not assume a new hormone prescription replaces a medicine already prescribed for bone health. Ask what each part of the plan is intended to accomplish. Nutrition, suitable activity, and fall prevention may also belong in the discussion based on your circumstances.
Keep the treatment goals distinct
A clinician may consider TRT for an appropriate testosterone-deficiency diagnosis while separately addressing fracture risk. Ask which symptoms, test findings, or outcomes support each proposed treatment. The broader promise of healthy aging is not a precise substitute for that explanation.
Our treatment-goals article helps prepare the conversation. If a provider recommends several services after a broad assessment, the Marek review also offers questions about responsibility and follow-up for findings outside the testosterone plan.
Leave with the next action for each concern
Write down whether the next step is another scan, a medication review, a discussion of falls, or follow-up of testosterone symptoms. Ask which clinician coordinates those actions and when you should expect review. A clear plan can connect the issues without pretending one treatment addresses all of them.
Use our first-appointment checklist to gather the records before you go. The goal is to understand the evidence and the individual recommendation, not to make a hormone decision from a slogan about stronger bones.
Sources & reading notes
Provider pages describe advertised services, not independently verified outcomes. Prices and eligibility may change. Checked September 20, 2026.